ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Bionomics Ltd Delisted | BNO | Australia | — | 1,430 |
| Arena Pharmaceuticals Inc Delisted | ARNA | United States of America | — | 1,418 |
| ArQule Inc Delisted | ARQL | United States of America | — | 1,384 |
| DIMERIX LIMITED | DXB | Australia | — | 1,381 |
| PYC THERAPEUTICS LIMITED | PYC | Australia | — | 1,372 |
| CG Invites Co., Ltd. | 083790 | South Korea | — | 1,370 |
| STARPHARMA HOLDINGS LIMITED | SPL | Australia | — | 1,360 |
| ARGENT BIOPHARMA LIMITED | RGT | Australia | — | 1,353 |
| Senhwa Biosciences, Inc. | 6492 | Taiwan | — | 1,343 |
| Ayala Pharmaceuticals, Inc. Delisted | — | United States of America | — | 1,324 |
| Durect Corporation Delisted | DRRX | United States of America | — | 1,320 |
| Helixmith Co., Ltd | 084990 | South Korea | — | 1,282 |
| Vical Incorporated Delisted | VICL | United States of America | — | 1,267 |
| Acer Therapeutics Inc. Delisted | — | United States of America | — | 1,253 |
| PERCHERON THERAPEUTICS LIMITED | PER | Australia | — | 1,243 |
| BIOCANCELL THERAPEUTICS INC. Delisted | — | United States of America | — | 1,213 |
| DMK Pharmaceuticals Corporation Delisted | DMK | United States of America | — | 1,210 |
| Molecular Templates, Inc. Delisted | — | United States of America | — | 1,208 |
| CYNATA THERAPEUTICS LIMITED | CYP | Australia | — | 1,197 |
| STCUBE | 052020 | South Korea | — | 1,196 |
| Adhera Therapeutics, Inc. Delisted | — | United States of America | — | 1,190 |
| INVION LIMITED | IVX | Australia | — | 1,189 |
| ALGORAE PHARMACEUTICALS LIMITED | 1AI | Australia | — | 1,183 |
| Sunesis Pharmaceuticals Inc Delisted | SNSS | United States of America | — | 1,178 |
| SYNAGEVA BIOPHARMA CORP Delisted | — | United States of America | — | 1,176 |
| Green Cross Cell Corporation Delisted | 031390 | South Korea | — | 1,172 |
| INFINITY PHARMACEUTICALS, INC. Delisted | — | United States of America | — | 1,172 |
| REPROS THERAPEUTICS INC. Delisted | — | United States of America | — | 1,171 |
| ACTINOGEN MEDICAL LIMITED | ACW | Australia | — | 1,132 |
| Sorrento Therapeutics, Inc. Delisted | — | United States of America | — | 1,125 |
| Eloxx Pharmaceuticals, Inc. | ELOX | United States of America | — | 1,121 |
| NKMAX Co., Ltd. | 182400 | South Korea | — | 1,082 |
| Immunomedics Inc Delisted | IMMU | United States of America | — | 1,079 |
| Hyper Corporation Inc. | 065650 | South Korea | — | 1,076 |
| Fibrocell Science Inc Delisted | FCSC | United States of America | — | 1,056 |
| MABVAX THERAPEUTICS HOLDINGS, INC. Delisted | — | United States of America | — | 1,050 |
| Dicot Pharma AB | DICOTBT | Sweden | — | 1,044 |
| NewLink Genetics Corporation Delisted | NLNK | United States of America | — | 1,037 |
| PRESCIENT THERAPEUTICS LIMITED | PTX | Australia | — | 1,035 |
| GENTA INC DE Delisted | — | United States of America | — | 1,021 |
| AVEO Pharmaceuticals Inc Delisted | AVEO | United States of America | — | 1,020 |
| LadRx Corp Delisted | — | United States of America | — | 1,018 |
| AUREKA LIMITED | AKA | Australia | — | 1,015 |
| RACURA ONCOLOGY LTD | RAC | Australia | — | 990 |
| PALATIN TECHNOLOGIES INC | PTN | United States of America | — | 972 |
| ATHERSYS, INC / NEW Delisted | — | United States of America | — | 960 |
| Genexine, Inc. | 095700 | South Korea | — | 960 |
| Regulus Therapeutics Inc Delisted | RGLS | United States of America | — | 956 |
| ALLOS THERAPEUTICS INC Delisted | — | United States of America | — | 952 |
| Diamyd Medical AB (publ) | DMYD | Sweden | — | 949 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.